Literature DB >> 15104949

[Nocebo effect: the other side of placebo].

Jordi Ferreres1, Josep-Eladi Baños, Magí Farré.   

Abstract

Administration of drugs is often followed by beneficial (placebo effects) and harmful (nocebo effects) effects that are not always related to their mechanism of action. Nocebo effects are rather unknown even when may be the source of many adverse reactions which could be erroneously attributed to drug therapy. Some mechanisms have been postulated which might be associated with the development of nocebo effects. Expectancy, learning and classical conditioning are probably important in the psychological domain. The neuropharmacological substrate is much less known yet an opioid peptide-cholecystokinin interaction has been suggested. At the clinical setting, a nocebo effect should be suspected in those patients who present common unspecific symptoms after drug administration and have a tendency to somatize. An early detection of these patients may contribute to the prevention of the nocebo effect.

Entities:  

Mesh:

Year:  2004        PMID: 15104949     DOI: 10.1016/s0025-7753(04)74289-x

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

Review 1.  Placebo: a brief updated review.

Authors:  Alfredo Jose Pardo-Cabello; Victoria Manzano-Gamero; Emilio Puche-Cañas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-08-09       Impact factor: 3.195

2.  Optimizing the pharmacological component of integrated balance therapy.

Authors:  Maurício Malavasi Ganança; Heloisa Helena Caovilla; Mário Sérgio Lei Munhoz; Cristina Freitas Ganança; Maria Leonor Garcia da Silva; Flavio Serafini; Fernando Freitas Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.